camilescafe.com
FDA Advisory Committee recommends US FDA approval of BRILINTA (ticagrelor) for Acute Coronary Syndromes Abbott's SIMCOR (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths Methodological characteristics of academic clinical drug trials - a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005 Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer IBM to Market UPMC 'Smart Room' Technology Fourth "Roche Continents" study week for 100 students GSK Rethinks Rep Compensation Allos Therapeutics Reports Second Quarter 2010 Financial Results A call for better quality measures from head of The Joint Commission

Members from: